ONO-5334: Clinical Trials

2 trials of ONO-5334, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 11Completed 1

Follow ONO-5334: new trials by email Literature Review of ONO-5334 trials Research Report on ONO-5334

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Effects of Food and Morning Versus Evening on Single and Multiple Doses of ONO-5334 in Healthy Post Menopausal Women
ONO-5334 - Healthy Post Menopausal Women
Phase 1 / Phase 2CompletedOno Pharmaceutical Co., Ltd.252011-06-012013-01-18
Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis
ONO-5334 - Osteoporosis, Osteopenia
Phase 2CompletedOno Pharma USA Inc2852007-10-012012-06-13

Conditions studied

Bone Diseases, Metabolic (1)  ·  Osteoporosis (1)

Sponsors

Ono Pharma USA Inc (1)  ·  Ono Pharmaceutical Co., Ltd. (1)

Countries

Netherlands (1)  ·  United Kingdom (1)

Top investigators

Tomohiro Kuwayama (1)

Results publications

PMID 23873670, PMID 26446770